FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * ABEJA VENTURES, LLC   2. Issuer Name and Ticker or Trading Symbol Accelerate Diagnostics, Inc [AXDX] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director __X__ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) 5661 NORTH CALLE MAYAPAN 3. Date of Earliest Transaction (Month/Day/Year) 03/06/2013 (Street) TUCSON, AZ 85718 4. If Amendment, Date Original Filed(Month/Day/Year) 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock (1) 03/06/2013   X   7,000,000 A $ 1.03 21,000,000 D   Common Stock (2) 03/06/2013   X   6,428,840 A $ 2 27,428,840 D   Common Stock (3) 03/06/2013   J   13,428,840 D $ 0 14,000,000 D   Common Stock (4) 03/06/2013   J   14,000,000 D $ 0 0 D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code (Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date (Month/Day/Year)

7. Title and Amount of Underlying Securities (Instr. 3 and 4)

8. Price of Derivative Security (Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)

11. Nature of Indirect Beneficial Ownership (Instr. 4)

Code

V

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Warrants (right to buy)

$ 1.03

03/06/2013

X

7,000,000

06/26/2012

06/26/2017

Common Stock

7,000,000

$ 0

7,000,000

D

Warrants (right to buy)

$ 2

03/06/2013

X

6,428,840

06/26/2012

06/26/2017

Common Stock

7,000,000

$ 0

571,160

D

Warrants (right to buy)

$ 2

03/06/2013

J

571,160

06/26/2012

06/26/2017

Common Stock

7,000,000

$ 0

0

D

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
ABEJA VENTURES, LLC 5661 NORTH CALLE MAYAPAN TUCSON, AZ 85718		X

Signatures

/s/ Daniel M. Mahoney, attorney-in-fact		03/08/2013
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Shares issued to Abeja Ventures, LLC upon its full exercise of a warrant to purchase 7,000,000 shares of Accelerate Diagnostics, Inc. common stock at an exercise price of $1.03 per share. Shares were issued directly to the members of Abeja Ventures, LLC on a pro rata basis in accordance with their membership interests.
(2)	Shares issued to Abeja Ventures, LLC upon its partial exercise of a warrant to purchase 7,000,000 shares of Accelerate Diagnostics, Inc. common stock at an exercise price of $2.00 per share. Shares were issued directly to the members of Abeja Ventures, LLC on a pro rata basis in accordance with their membership interests (with the remaining 571,160 warrant shares being assigned to the members that did not desire to exercise the warrant to the full extent of their membership interest).
(3)	Reflects distribution in kind to members of Abeja Ventures, LLC in connection with such entity's exercise of the warrants, as described above in notes (1) and (2).
(4)	Reflects distribution in kind (of remaining shares) to members of Abeja Ventures, LLC on a pro rata basis in accordance with their membership interests.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.